Stay updated on SubQ Daratumumab in High-Risk Smoldering Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the SubQ Daratumumab in High-Risk Smoldering Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SubQ Daratumumab in High-Risk Smoldering Multiple Myeloma Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 to the history; removed the older site-wide notices including the lapse in government funding message and Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-11T01:36:56.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A new 2026-01-30 version entry was added with a Study Status change and Revision: v3.4.1, and the prior 2025-12-23 entry (Revision: v3.4.0) was removed.
    Difference
    0.5%
    Check dated 2026-02-03T22:29:34.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The record history page now shows a glossary toggle and uses green/red highlights to distinguish additions and deletions, with an updated revision label (v3.4.0). The No FEAR Act data text was removed in this update.
    Difference
    0.4%
    Check dated 2026-01-27T20:48:46.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4, indicating a minor site revision with no visible changes to study data or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-20T14:37:06.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    Added entries for Results Posted, More Information, Adverse Events, Outcome Measures (Results), Baseline Characteristics, Participant Flow, and Document Section under the Study Record History dated 2025-12-23. Removed the 'Results Submitted' entry dated 2025-12-08.
    Difference
    0.5%
    Check dated 2025-12-29T23:05:31.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    Revision: v3.3.3 was added to the page footer, and the HHS Vulnerability Disclosure link and Revision: v3.3.2 were removed. This appears to be a routine maintenance update that does not affect trial details or user actions.
    Difference
    0.1%
    Check dated 2025-12-22T22:44:56.000Z thumbnail image

Stay in the know with updates to SubQ Daratumumab in High-Risk Smoldering Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SubQ Daratumumab in High-Risk Smoldering Multiple Myeloma Clinical Trial page.